Rheumatoid arthritis.ppt

  1. 1、本文档共14页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Rheumatoidarthritis整理ppt

Rheumatoid arthritis How Is Rheumatoid Arthritis Diagnosed? The first step in the diagnosis of rheumatoid arthritis is a meeting between the doctor and the patient. A newer, more specific blood test for rheumatoid arthritis is the citrulline antibody test. The sedimentation rate (sed rate), another blood test for RA, is a measure of how fast red blood cells fall to the bottom of a test tube. Joint X-rays can also be helpful in monitoring the progression of rheumatoid disease and joint damage over time. In arthrocentesis, a sterile needle and syringe are used to drain joint fluid out of the joint for study in the laboratory. What is the treatment for rheumatoid arthritis? There is no known cure for rheumatoid arthritis. To date, the goal of treatment in rheumatoid arthritis is to reduce joint inflammation and pain, maximize joint function, and prevent joint destruction and deformity. Rheumatoid Arthritis Medications Two classes of medications are used in treating rheumatoid arthritis: fast-acting first-line drugs and slow-acting second-line drugs“ The first-line drugs:such as aspirin and cortisone (corticosteroids)(可的松), are used to reduce pain and inflammation. The slow-acting second-line drugs, such as methotrexate (Rheumatrex, Trexall)(甲氨蝶呤), and hydroxychloroquine (Plaquenil)(羟化氯喹), promote disease remission and prevent progressive joint destruction. Newer second-line drugs (DMARDs) for the treatment of rheumatoid arthritis include leflunomide (Arava) (来氟米特) etanercept (Enbrel)(依那西普) infliximab (Remicade)(英夫利昔) anakinra (Kineret)(阿那白滞素) adalimumab (Humira)(阿木达单抗) rituximab (Rituxan)(利妥昔单抗) abatacept (Orencia)(阿巴西普) golimumab (Simponi)(戈利木单抗) certolizumab pegol (Cimzia)(妥珠单抗) tocilizumab (Actemra)(塔西单抗) tofacitinib (Xeljanz). (托法替尼) Each of these medications can increase the risk for infections, and the development of any infections should be reported to the health care professional when taking these newer second-line drugs. In some cases with s

文档评论(0)

zyzsaa + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档